Acasti Pharma Announces Closing of US$10 Million Firm Commitment Offering of Common Shares and Warrants Dec 27, 2017
Acasti Pharma Clarifies Term of Proposed Strategic Partnership with Leading China Pharmaceutical Company Nov 22, 2017
Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner Nov 20, 2017
Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program Nov 7, 2017
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures Oct 4, 2017
Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM Aug 16, 2017
